GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 48 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $53,000 | +65.6% | 42,700 | +55.3% | 0.00% | – |
| Q4 2021 | $32,000 | -54.3% | 27,500 | +7.2% | 0.00% | – |
| Q1 2021 | $70,000 | -92.7% | 25,659 | -93.5% | 0.00% | -100.0% |
| Q4 2020 | $958,000 | +98.8% | 395,763 | +87.8% | 0.00% | – |
| Q3 2020 | $482,000 | +81.9% | 210,694 | +82.6% | 0.00% | – |
| Q2 2020 | $265,000 | +0.4% | 115,371 | -24.7% | 0.00% | – |
| Q1 2020 | $264,000 | -54.4% | 153,296 | -45.2% | 0.00% | – |
| Q4 2019 | $579,000 | -1.9% | 279,511 | +37.4% | 0.00% | – |
| Q3 2019 | $590,000 | -9.5% | 203,362 | +22.2% | 0.00% | -100.0% |
| Q2 2019 | $652,000 | – | 166,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $878,000 | 2.94% |
| COMMODORE CAPITAL LP | 2,929,447 | $6,855,000 | 2.39% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $462,000 | 0.74% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,615,000 | 0.54% |
| BVF INC/IL | 4,012,404 | $9,389,000 | 0.35% |
| NEA Management Company, LLC | 10,376,936 | $24,282,000 | 0.32% |
| Avoro Capital Advisors LLC | 5,084,184 | $11,897,000 | 0.21% |
| Diametric Capital, LP | 69,977 | $164,000 | 0.12% |
| Boxer Capital, LLC | 1,134,453 | $2,655,000 | 0.09% |
| Ikarian Capital, LLC | 200,000 | $468,000 | 0.04% |